Significant receptor affinities of metabolites and a degradation product of mometasone furoate

Respiratory Research

Volumn 5, Issue , 2004, Pages

  Valotis, Anagnostis ^a   Högger, Petra ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

9,11 EPOXY MOMETASONE FUROATE; DEXAMETHASONE; DRUG METABOLITE; FLUNISOLIDE; GLUCOCORTICOID RECEPTOR; HYDROXYCORTICOSTEROID; MOMETASONE FUROATE; TRIAMCINOLONE ACETONIDE; UNCLASSIFIED DRUG; PREGNANE DERIVATIVE;

ARTICLE; BINDING COMPETITION; DRUG BLOOD LEVEL; DRUG DEGRADATION; DRUG DETERMINATION; DRUG RECEPTOR BINDING; HUMAN; HUMAN TISSUE; LUNG PARENCHYMA; RECEPTOR AFFINITY; REFERENCE VALUE; BIOREMEDIATION; IN VITRO STUDY; LUNG; METABOLISM; PROTEIN BINDING;

BIODEGRADATION, ENVIRONMENTAL; HUMANS; LUNG; PREGNADIENEDIOLS; PROTEIN BINDING; RECEPTORS, GLUCOCORTICOID;

EID: 10644237880     PISSN: 1465993X     EISSN: None     Source Type: Journal    
DOI: 10.1186/1465-9921-5-7     Document Type: Article

References (19)

1. Sharpe M, Jarvis B: Inhaled mometasone furoate: a review of its use in adults and adolescents with persistent asthma. Drugs 2001, 61:1325-1350.
2. Trangsrud AJ, Whitaker AL, Small RE: Intranasal corticosteroids for allergic rhinitis. Pharmacotherapy 2002, 22:1458-1467.
3. Brazzini B, Pimpinelli N: New and established topical corticosteroids in dermatology: clinical pharmacology and therapeutic use. Am J Clin Dermatol 2002, 3:47-58.
4. O'Connor B, Bonnaud G, Haahtela T, Luna JM, Querfurt H, Wegener T, Lutsky BN: Dose-ranging study of mometasone furoate dry powder inhaler in the treatment of moderate persistent asthma using fluticasone propionate as an active comparator. Ann Allergy Asthma Immunol 2001, 86:397-404.
5. Würthwein G, Rehder S, Rohdewald P: Lipophilicity and receptor affinity of glucocorticoids. Pharm Ztg Wiss 1992, 4:161-167.
6. Hogger P, Rohdewald P: Binding kinetics of fluticasone propionate to the human glucocorticoid receptor. Steroids 1994, 59:597-602.
7. Valotis A, Neukam K, Ehlert O, Högger P: Human receptor kinetics, tissue binding affinity and stability of mometasone fuorate. J Pharm Sci 2004, 93:1337-1350.
8. Affrime MB, Cuss F, Padhi D, Wirth M, Pai S, Clement RP, Lim J, Kantesaria B, Alton K, Cayen MN: Bioavailability and metabolism of mometasone furoate following administration by metereddose and dry-powder inhalers in healthy human volunteers. J Clin Pharmacol 2000, 40:1227-1236.
9. Derendorf H, Daley-Yates PT, Pierre LN, Efthimiou J: Systemic bioavailability of inhaled steroids: the importance of appropriate and comparable methodology. Eur Respir J 2001, 17:157-158.
10. Derendorf H, Daley-Yates PT, Pierre LN, Efthimiou J: Bioavailability and metabolism of mometasone furoate: pharmacology versus methodology. J Clin Pharmacol 2002, 42:383-387.
11. Affrime MB, Kosoglou T, Thonoor CM, Flannery BE, Herron JM: Mometasone furoate has minimal effects on the hypothalamic-pituitary-adrenal axis when delivered at high doses. Chest 2000, 118:1538-1546.
12. Lipworth BJ: Mometasone furoate levels. Chest 2001, 120:1034-1035.
13. Teng XW, Cutler DJ, Davies NM: Mometasone furoate degradation and metabolism in human biological fluids and tissues. Biopharm Drug Dispos 2003, 24:321-333.
14. Isogai M, Shimizu H, Esumi Y, Terasawa T, Okada T, Sugeno K: Binding affinities of mometasone furoate and related compounds including its metabolites for the glucocorticoid receptor of rat skin tissue. J Steroid Biochem Mol Biol 1993, 44:141-145.
15. Teng XW, Cutler DC, Davies NM: Degradation kinetics of mometasone furoate in aqueous systems. Int J Pharm 2003, 259:129-141.
16. Teng XW, Cutler DJ, Davies NM, Cutler DC: Kinetics of metabolism and degradation of mometasone furoate in rat biological fluids and tissues. J Pharm Pharmacol 2003, 55:617-630.
17. Hochhaus G, Moellmann HW: Binding affinities of rimexolone (ORG 6216), flunisolide and their putative metabolites for the glucocorticoid receptor of human synovial tissue. Agents Actions 1990, 30:377-380.
18. Grogan WM, Phillips VM, Schuetz EG, Guzelian PS, Watlington CO: Corticosterone 6 beta-hydroxylase in A6 epithelia: a steroidinducible cytochrome P-450. Am J Physiol 1990, 258:C480-488.
19. Kilpio K, Hannuksela M: Corticosteroid allergy in asthma. Allergy 2003, 58:1131-1135.